About this item:

151 Views | 96 Downloads

Author Notes:

Correspondence to: M. Eric Gershwin, M.D., Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, 451 Health Sciences Drive, Suite 6510, Davis, CA 95616; Telephone: 530-752-2884; Fax: 530-752-4669; megershwin@ucdavis.edu.

The authors thank Masanobu Tsuda and Yoko Miyamoto Ambrosini for technical support in this experiment.

The authors thank Ms. Nikki Phipps for support in preparing this article.

Subjects:

Research Funding:

Financial support provided by National Institutes of Health grant, DK090019.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Gastroenterology & Hepatology
  • PRIMARY BILIARY-CIRRHOSIS
  • PYRUVATE-DEHYDROGENASE COMPLEX
  • DOMINANT-NEGATIVE FORM
  • II MICE
  • INFLUENZA INFECTION
  • EPITHELIAL-CELLS
  • DENDRITIC CELLS
  • E2 COMPONENT
  • MOUSE MODEL
  • IDENTIFICATION

Clonality, Activated Antigen-Specific CD8(+) T Cells, and Development of Autoimmune Cholangitis in dnTGF beta RII Mice

Show all authors Show less authors

Tools:

Journal Title:

Hepatology

Volume:

Volume 58, Number 3

Publisher:

, Pages 1094-1104

Type of Work:

Article | Post-print: After Peer Review

Abstract:

There are several murine models described with features similar to human primary biliary cirrhosis (PBC). Among these models, the one which has the closest serologic features to PBC is a mouse with a T-cell-restricted expression of the dominant negative transforming growth factor β receptor type II (dnTGFβRII). Our work has demonstrated that CD8+ T cells from dnTGFβRII mice transfer autoimmune cholangitis to Rag1-/- recipients. However, it remained unclear whether the autoimmune cholangitis was secondary to an intrinsic function within CD8+ T cells or due to the abnormal TGFβR environment within which CD8+ T cells were generated. To address this mechanistic issue, we used our dnTGFβRII, OT-I/Rag1-/-, OT-II/Rag1-/- mice and in addition generated OT-I/dnTGFβRII/Rag1-/-, and OT-II/dnTGFβRII/Rag1-/- mice in which the entire T-cell repertoire was replaced with ovalbumin (OVA)-specific CD8+ or CD4+ T cells, respectively. Importantly, neither the parental OT-I/dnTGFβRII/Rag1-/- mice and/or OT-II/dnTGFβRII/Rag1-/- mice developed cholangitis. However, adoptive transfer demonstrated that only transfer of CD8+ T cells from dnTGFβRII mice but not CD8+ T cells from OT-I/Rag1-/- mice or from OT-I/dnTGFβRII/Rag1-/- mice transferred disease. These data were not secondary to an absence of CD4+ T cell help since a combination of CD8+ T cells from OT-I/dnTGFβRII/Rag1-/- and CD4+ T cells from OT II/dnTGFβRII/Rag1-/- or CD8+ T cells from OT-I/dnTGFβRII/Rag1-/- with CD4+ T cells from OT-II/Rag1-/- mice failed to transfer disease. Conclusion: Defective TGFβRII signaling, in addition to clonal CD8+ T cells that target biliary cells, are required for induction of autoimmune cholangitis. (Hepatology 2013;53:1094-1104).

Copyright information:

© 2013 by the American Association for the Study of Liver Diseases.

Export to EndNote